Lynparza 150 mg/1 (Olaparib TABLET, FILM COATED) 150 mg/1

Lynparza 150 mg tablets are a pharmaceutical product used in cancer treatment. This medication is designed to target specific genetic mutations, offering a targeted approach to therapy.

Strength

150 mg/1

Pack Size

60 TABLET, FILM COATED in 1 BOTTLE (0310-0679-60)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lynparza 150 mg tablets are primarily used in the treatment of certain types of cancer. This medication is often prescribed for patients with specific genetic mutations, such as BRCA mutations, which are commonly found in ovarian and breast cancers. Lynparza is a type of PARP inhibitor, which works by blocking an enzyme involved in DNA repair, thereby helping to slow the growth of cancer cells. Patients should consult their healthcare provider to determine if Lynparza is suitable for their condition.

Side Effects

Common effects of Lynparza 150 mg tablets may include fatigue, nausea, and anemia. Some patients may also experience vomiting, diarrhea, or a decrease in appetite. It is important to note that individual responses to medication can vary, and not all users will experience these effects. Patients should report any persistent or severe side effects to their healthcare provider.

Precautions & Warnings

Lynparza 150 mg tablets should be handled with care and stored as directed. This medication is intended for oral use and should be taken exactly as prescribed by a healthcare provider. Patients should avoid breaking or crushing the tablets unless instructed to do so. It is also important to inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Lynparza 150 mg tablets may interact with certain medications, including those that are metabolized by the liver. Patients should avoid consuming alcohol while taking Lynparza, as it may increase the risk of side effects. It is also important to inform your healthcare provider about any other medications, supplements, or herbal products you are taking to avoid potential interactions.

Frequently Asked Questions

Lynparza 150 mg tablets are used in the treatment of certain types of cancer, particularly those with BRCA mutations.

Lynparza 150 mg tablets should be taken orally, exactly as prescribed by your healthcare provider.

Common side effects of Lynparza may include fatigue, nausea, and anemia.

Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.

It is generally advised to avoid alcohol while taking Lynparza to reduce the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.